Details of the Drug
General Information of Drug (ID: DMKYE16)
| Drug Name |
1,3-Diethyl-3,7-dihydro-purine-2,6-dione
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
1,3-Diethylxanthine; SC 2079; 5169-95-9; 1,3-diethyl-3,9-dihydro-1h-purine-2,6-dione; CHEMBL416013; UNII-4550Q64O79; 4550Q64O79; 1,3-Diethylxantine; Xanthine,3-diethyl-; NSC 515479; 1,3-diethyl-xanthine; AC1L2QSV; AC1Q6LGQ; 1,3-diethyl-1H-purine-2,6(3H,7H)-dione; SCHEMBL515564; BDBM82021; CTK8I9744; CTK8D7769; DTXSID40199644; 1H-Purine-2,6-dione, 1,3-diethyl-3,7-dihydro- (9CI); GIMNFISWKTZFKJ-UHFFFAOYSA-N; Xanthine, 1,3-diethyl- (8CI); NSC515479; 1,3-diethyl-7H-purine-2,6-dione; AKOS030616954; NSC_101420; NSC-515479; CAS_101420
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 208.22 | |||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 0.9 | ||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||||||


